A Study Based on CT Radiomics for Distinguishing Benign From Malignant Renal Tumors and Assessing Their Aggressiveness.

Central South University

Status: Active, not recruiting

Conditions: Renal Cell Carcinoma (RCC)

Study type: Observational

Funder types: Other

Identifiers

NCT07060248

JLiu

Details and patient eligibility

About

To evaluate the efficacy of CT-based radiomics in differentiating benign from malignant renal tumors, predicting nuclear grading of renal cell carcinoma, and assessing T-stage of renal tumors, thereby exploring its clinical application value.

Enrollment: 700 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Pathologically confirmed renal tumors (including clear cell renal cell carcinoma, papillary renal cell carcinoma, chromophobe renal cell carcinoma, angiomyolipoma, and oncocytoma).
• Contrast-enhanced CT scan was performed preoperatively.

Exclusion criteria

• Pure cystic clear cell renal cell carcinoma
• Poor-quality CT images

Trial design

700 participants in 1 patient group

RCC group, non-RCC group; WHO/ISUP low-grade ccRCC, high-grade ccRCC; T3 tumor, T1-T2 tumor